These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Transforming growth factor-beta suppressed Id-1 Expression in a smad3-dependent manner in LoVo cells.
    Author: Song H, Guo B, Zhang J, Song C.
    Journal: Anat Rec (Hoboken); 2010 Jan; 293(1):42-7. PubMed ID: 19798702.
    Abstract:
    TGF-beta plays an important role in regulating cell differentiation and proliferation in human cancers such as colorectal cancer. Id-1 has been identified as a marker in colorectal cancer progression. The aim of this study was to investigate the role of TGF-beta in regulating Id-1 in LoVo cells. siRNA was used to silence smad2, smad3, and p38 MAPK gene expression in Lovo cells. Interference efficiency and the role of TGF-beta on Id-1 expression were analyzed using a luciferase reporter assay, RT-PCR, and Western blotting. Cell viability was determined using the MTT assay. In this study, we demonstrated that TGF-beta1 downregulated Id-1 protein expression in LoVo cells. Smad2 and smad3 siRNA inhibited TGF-beta1-induced 4xSBE luciferase reporter activity. p38 MAPK siRNA inhibited TGF-beta1-induced 3xAP-1 luciferase reporter activity. However, the suppression of Id-1 by TGF-beta1 was recovered by smad3 siRNA but not smad2 or p38 MAPK siRNA. Moreover, TGF-beta1 stimulated cellular proliferation and p21(Waf1) protein expression, which might be mediated by suppressing Id-1 expression. In conclusion, this study demonstrated that TGF-beta1 suppressed Id-1 expression in a smad3-dependent manner in LoVo cells using RNAi technology. These results provide new insight into the mechanisms of TGF-beta function in colorectal cancer cells.
    [Abstract] [Full Text] [Related] [New Search]